Back to Screener

DataMeds AI, Inc. - Common Stock (MEDS)

NASDAQ Nano Cap
$3.17
Market Cap: $10M
Data as of Jun 30, 2026 (TTM)

Investment Snapshot

  • Piotroski F-Score 3/9 — signs of financial weakness
  • Negative net margin (-474.4%) — currently unprofitable
  • Revenue growing at 29% annually

DataMeds AI, Inc. - Common Stock (MEDS) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $10 million . Key value metrics: Piotroski F-Score 3 out of 9 .

Value Score

Key Metrics

P/E Ratio
EPS
$-21.91
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio
Data sourced from SEC EDGAR and Polygon.io. Methodology.

DataMeds AI, Inc. - Common Stock — Fundamental Analysis Summary

StockPik's composite Value Score for MEDS is 38/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

MEDS reports a thin gross margin of 7.7% and a negative operating margin of -356.4%.

MEDS shows revenue growing at 29% year-over-year, with earnings declining at 1,377%.

How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
MEDP
Next
MEG